Ishita Drugs & Industries Share Price

CMP as on27-Nov-20 15:42

₹ 25.40
-0.05 -0.2%

Open

₹ 25.45

Turnover (lac)

Prev. Close

₹ 25.45

Day's Vol (shares)

₹ 2,200

Day's Range

₹ 24.20
₹ 25.45

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Oct-2020 - -
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2020 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board Directors of the Company is scheduled to be held on Monday, November 09, 2020, inter-alia, to consider, approve and take on record the Unaudited Financial Results of the company for the quarter and half-year ended on September 30, 2020, as required under the Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.
Board Meeting - 27-Aug-2020 - -
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2020 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board Directors of the Company is scheduled to be held on Monday , August 31, 2020 inter-alia, for Appointment of Company Secretary cum Compliance Officer, as required under the Regulation 6(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. This is to inform you that the Board of Director of the company at its meeting held today on Monday 31st, day of August 2020 has: 1) Approved the appointment of Mr. Vijay Shah as Company Secretary cum Compliance officer. (As per BSE Announcement Dated on 31/8/2020)
Board Meeting - 05-Aug-2020 - -
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2020 ,inter alia, to consider and approve 1. The Unaudited Financial Results for Of the Company for the Quarter ended on 30th June, 2020. 2. Any other matter with permission of the Chair. This is to inform you that the Board of directors of the Company at its meeting held today on Tuesday, the 13th Day of August, 2020 have approved the Unaudited Financial Results of the Company along with the Limited Review Report for the quarter ended on 30th June, 2020 pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015.. (As per BSE Announcement Dated on 13/8/2020)
Board Meeting - 23-Jun-2020 - -
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve 1. Appointment of secretarial auditor 2. Appointment of internal auditor 3. Other business with the permission of chairman 4. Resignation of Company Secretary 5. Resignation of independent director 6. Take disclosure of interest 7. Consider and approve the financial results for year ended 31.03.2020. We hereby inform you that the Board of Directors of the Company at its meeting held on 30th June, 2020 has Approved the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March, 2020 and other businesses. We hereby inform you that the Board of Directors of the Company at its meeting held on 30th June, 2020 has Approved the Audited Standalone Financial Results including Cash Flow Statement of the Company for the quarter and year ended on 31st March, 2020 and other businesses. Resignation of an independent director. (As Per BSE Announcement Dated 30.06.2020) We hereby inform you that the Board of Directors of the Company at its meeting held on 30th June, 2020 has Approved the Audited Standalone Financial Results including Cash Flow Statement of the Company for the quarter and year ended on 31st March, 2020 and other businesses. (As Per BSE Announcement Dated on 28/07/2020)
Board Meeting - 04-Feb-2020 - -
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve 1. The Unaudited Financial Results for Of the Company for the Quarter ended on 31st December, 2019. 2. Any other matter with permission of the Chair. This is to inform you that the Board of directors of the Company at its meeting held today on Tuesday, the 11th Day of February, 2020 have approved the Unaudited Financial Results of the Company along with the Limited Review Report for the quarter ended on 31st December, 2019 pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015. (As Per BSE Announcement Dated 11.02.2020)